Javascript must be enabled to continue!
Evaluation of non-invasive markers of liver fibrosis in chronic hepatitis B patients in a sub- saharan African setting: Transient elastography Versus APRI, FIB4, GTT/ Platelet scores
View through CrossRef
Abstract
Background: Non-invasive markers which use routine laboratory tests are less expensive and highly needed to assess and stage liver fibrosis in chronic hepatitis B patients in Sub Saharan Africa. We aimed at evaluating liver fibrosis, using Aspartate aminotransferase to Platelet Ratio Index (APRI), Fibrosis Index Based on 4 factors (FIB4), and Gamma glutamyl transpeptidase to Platelet Ratio (GPR) in chronic hepatitis B patients with transient elastography as the reference so as to choose an alternative to transient elastography.
Method: We carried out a cross-sectional study using the records of patients who attended the Douala General Hospital and Marie O Polyclinic Douala between 2012 to 2017. Non-invasive tests were compared with Transient Elastography. The spearman coefficient was used to determine correlation. The sensitivity, specificity, positive predictive values and negative predictive values were used to get the optimal cut off values. The diagnostic accuracy was estimated by calculating the area under the Receiver Operating Characteristic Curve (ROC). P<0.05 was considered statistically significant.
Results: Of the 243 patient records studied, the median age or inter quartile range (IQR) was 35(29-42) years with a male predominance of 73.7%. More than 60% of the study population had normal transaminases. Significant fibrosis was found in 88(36.2%) patient and 32(13.7%) patient had cirrhosis. APRI had the best cut off values and highest area under the ROC Curve, for significant fibrosis and cirrhosis with 0.55(0.823 95% CI [0.769-0.869], P<0.001) and 0.65(0.84 95% CI [0.788-0.884], P<0.005) respectively.
Conclusion: APRI, had the best diagnostic properties to detect liver fibrosis and cirrhosis in patients with Chronic Hepatitis B in Douala. The cut off values are 0.55 and 0.65 for significant fibrosis and cirrhosis respectively.
Title: Evaluation of non-invasive markers of liver fibrosis in chronic hepatitis B patients in a sub- saharan African setting: Transient elastography Versus APRI, FIB4, GTT/ Platelet scores
Description:
Abstract
Background: Non-invasive markers which use routine laboratory tests are less expensive and highly needed to assess and stage liver fibrosis in chronic hepatitis B patients in Sub Saharan Africa.
We aimed at evaluating liver fibrosis, using Aspartate aminotransferase to Platelet Ratio Index (APRI), Fibrosis Index Based on 4 factors (FIB4), and Gamma glutamyl transpeptidase to Platelet Ratio (GPR) in chronic hepatitis B patients with transient elastography as the reference so as to choose an alternative to transient elastography.
Method: We carried out a cross-sectional study using the records of patients who attended the Douala General Hospital and Marie O Polyclinic Douala between 2012 to 2017.
Non-invasive tests were compared with Transient Elastography.
The spearman coefficient was used to determine correlation.
The sensitivity, specificity, positive predictive values and negative predictive values were used to get the optimal cut off values.
The diagnostic accuracy was estimated by calculating the area under the Receiver Operating Characteristic Curve (ROC).
P<0.
05 was considered statistically significant.
Results: Of the 243 patient records studied, the median age or inter quartile range (IQR) was 35(29-42) years with a male predominance of 73.
7%.
More than 60% of the study population had normal transaminases.
Significant fibrosis was found in 88(36.
2%) patient and 32(13.
7%) patient had cirrhosis.
APRI had the best cut off values and highest area under the ROC Curve, for significant fibrosis and cirrhosis with 0.
55(0.
823 95% CI [0.
769-0.
869], P<0.
001) and 0.
65(0.
84 95% CI [0.
788-0.
884], P<0.
005) respectively.
Conclusion: APRI, had the best diagnostic properties to detect liver fibrosis and cirrhosis in patients with Chronic Hepatitis B in Douala.
The cut off values are 0.
55 and 0.
65 for significant fibrosis and cirrhosis respectively.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
1260-P: Verifying the Use of FIB4 and BARD Scores to Predict Advanced Fibrosis Using Transient Elastography in People with Type 2 Diabetes in a Tertiary Care Center in India
1260-P: Verifying the Use of FIB4 and BARD Scores to Predict Advanced Fibrosis Using Transient Elastography in People with Type 2 Diabetes in a Tertiary Care Center in India
Background: There is a high prevalence of nonalcoholic fatty liver disease in people with type 2 diabetes. Liver biopsy is the gold standard for diagnosing advanced fibrosis but is...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
VAP score as a novel non‐invasive liver fibrosis model in patients with chronic hepatitis C
VAP score as a novel non‐invasive liver fibrosis model in patients with chronic hepatitis C
AimAssessment of liver fibrosis in chronic hepatitis C (CHC) patients is necessary before antiviral treatment. This study aimed to evaluate the effectiveness of eight non‐invasive ...
From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
Chronic liver disease is a late stage of progressive hepatic fibrosis. It consists of functional and structural disruptions in most chronic liver diseases. An accurate diagnosis al...
Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C
Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C
Pentraxin 3 (PTX3) plays a pathogenic role in experimental models of chronic liver injury and contributes to the progression of fibrosis. The detection of advanced fibrosis (METAVI...
COMPARATIVE ACCURACY OF 2-D SHARE WAVE ELASTOGRAPHY WITH CHILD PUGH SCORING IN LIVER FIBROSIS
COMPARATIVE ACCURACY OF 2-D SHARE WAVE ELASTOGRAPHY WITH CHILD PUGH SCORING IN LIVER FIBROSIS
Background: Liver fibrosis is a progressive response to chronic liver injury, resulting in scar tissue formation and potential evolution into cirrhosis. Early and accurate staging ...
CORRELATION BETWEEN SERUM LIVER ENZYMES AND FIBROSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS. A CROSS-SECTIONAL STUDY
CORRELATION BETWEEN SERUM LIVER ENZYMES AND FIBROSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS. A CROSS-SECTIONAL STUDY
Background: One of the major chronic liver diseases in the world is NAFLD which tends to start as mere steatosis but tends to evolve into fibrosis and cirrhosis. Serum liver enzyme...

